Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Pancreatic Neoplasms 3 Pancreatic Cyst 2 Wilms Tumor 1 Uveal Melanoma 1 Thyroid Nodule 1 Thyroid Diseases 1 Prostatic Neoplasms 1 Peutz-Jeghers Syndrome 1 Pancreatitis, Chronic 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Intestinal Neuroendocrine Tumor 1 Hyperthyroidism 1 Hip Fractures 1 Hematologic Neoplasms 1 Goiter 1 Glioma 1 Glioblastoma 1 Frailty 1 Fractures, Spontaneous 1 Financial Stress 1

Interventions

pembrolizumab 91 Carboplatin 80 Specimen Handling 77 Magnetic Resonance Spectroscopy 64 Pemetrexed 62 Cisplatin 49 durvalumab 45 Paclitaxel 40 Nivolumab 35 atezolizumab 31 Radiotherapy 30 osimertinib 29 Radiosurgery 29 Blood Specimen Collection 27 Biopsy 26 Immunoglobulin G 24 Gemcitabine 24 Docetaxel 24 Disulfides 23 Standard of Care 21 Drug Therapy 21 Taxes 20 Etoposide 20 Radiation 17 Practice Guidelines as Topic 17 X-Rays 15 Educational Status 15 130-nm albumin-bound paclitaxel 15 Surveys and Questionnaires 14 Bevacizumab 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Data Collection × 1 year × Clear all

NCT07590947 2026-05-15

ROSE

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡